111, Inc. ADR (YI)

Profile

https://corporate.111.com.cn

111, Inc. American Depositary Receipt (ADR) represents shares of 111, Inc., a Chinese healthcare company with a comprehensive online and offline platform serving the healthcare ecosystem in China. The company operates through two main segments: B2C, serving individual consumers, and B2B, catering to corporate clients such as pharmacies, wholesalers, and medical professionals. Its offerings include prescription and over-the-counter medications, nutritional supplements, medical supplies, personal care products, and value-added services like online consultations and e-prescriptions. 111, Inc. also manages a network of retail pharmacies and provides logistics, warehousing, software development, and consulting services, integrating multiple facets of healthcare distribution and services. The ADR facilitates access for international investors to the company’s equity, contributing to cross-border capital flows and investment in the Chinese healthcare market. Trading of the ADR occurs on various exchanges, including Börse Berlin, where it forms part of a diverse portfolio of international securities available to global investors.